Item 9 Labs (Item 9 Labs) GF Value : $0.95 (As of May. 14, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Item 9 Labs GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-14), Item 9 Labs's share price is $0.0001. Item 9 Labs's GF Value is $0.95. Therefore, Item 9 Labs's Price-to-GF-Value for today is 0.00.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Item 9 Labs is Possible Value Trap, Think Twice.

Item 9 Labs (OTCPK:INLB) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Item 9 Labs's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.0001	/	0.95
	=	0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Item 9 Labs GF Value Related Terms

Thank you for viewing the detailed overview of Item 9 Labs's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Item 9 Labs (Item 9 Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Item 9 Labs Corp (OTCPK:INLB) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

2111 E. Highland Avenue, Suite B375, Phoenix, AZ, USA, 85016

Website

https://www.item9labscorp.com

Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. It also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.

Executives

Taylor Lawrence X. Iii	director	2727 N 3RD STREET, SUITE 201, PHOENIX AZ 85004
Eric Kutscher	director	2727 N 3RD STREET, SUITE 201, PHOENIX AZ 85004
Michael P Keskey	director	C/O ITEM 9 LABS, 2727 N. 3RD STREET, SUITE 201, PHOENIX AZ 85004
Douglas P Bowden	director	C/O ITEM 9 LABS 2727 N. 3RD STREET., SUITE 201, PHOENIX AZ 85004
Christopher Leland Wolven	officer: Chief Operating Officer	5743 N 19TH ST, PHOENIX AZ 85016
Sara Gullickson	director, officer: Chief Executive Officer	1709 BETHANY RD, PHOENIX AZ 85016
Andrew Douglas Bowden	director	3621 N 39TH ST, PHOENIX AZ 85018
Robert E Mikkelsen	officer: CFO, Secretary, Treasurer	2033 N OVERFIELD RD, CASA GRANDE AZ 85194
Patrick Sean Dugan	10 percent owner	2033 N OVERFIELD RD, CASA GRANDE AZ 85194
Andrew Poirier	10 percent owner	1946 E RANCHO DR, PHOENIX AZ 85016
Bryce Skalla	director, officer: President	2033 N OVERFIELD RD, CASA GRANDE AZ 85194
Cohen Daniel E Md	director, officer: President	10035 GRISTMILL RIDGE, EDEN PRAIRIE MN 55347
Hayjour Family Limited Partnership	director, officer: President & CEO	10799 N 90TH STREET, SUITE 200, SCOTTSDALE AZ 85260
Jessica L Smith	officer: CFO, Secretary, Treasurer	8399 E. INDIAN SCHOOL RD., SUITE 202, SCOTTSDALE AZ 85251
Lorrie Henderson	officer: Chief Operating Officer	8399 E INDIAN SCHOOL RD, SUITE 202, SCOTTSDALE AZ 85251